These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23095249)
1. Strategy for eliciting antigen-specific CD8+ T cell-mediated immune response against a cryptic CTL epitope of merkel cell polyomavirus large T antigen. Gomez BP; Wang C; Viscidi RP; Peng S; He L; Wu TC; Hung CF Cell Biosci; 2012 Oct; 2(1):36. PubMed ID: 23095249 [TBL] [Abstract][Full Text] [Related]
2. Development of a DNA vaccine targeting Merkel cell polyomavirus. Zeng Q; Gomez BP; Viscidi RP; Peng S; He L; Ma B; Wu TC; Hung CF Vaccine; 2012 Feb; 30(7):1322-9. PubMed ID: 22210138 [TBL] [Abstract][Full Text] [Related]
3. Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen. Gomez B; He L; Tsai YC; Wu TC; Viscidi RP; Hung CF Cell Biosci; 2013 Jul; 3(1):29. PubMed ID: 23856459 [TBL] [Abstract][Full Text] [Related]
4. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576 [TBL] [Abstract][Full Text] [Related]
5. LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition. Buchta Rosean C; Leyder EC; Hamilton J; Carter JJ; Galloway DA; Koelle DM; Nghiem P; Heiland T Front Immunol; 2023; 14():1253568. PubMed ID: 37711623 [TBL] [Abstract][Full Text] [Related]
6. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8 Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557 [TBL] [Abstract][Full Text] [Related]
7. Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells. Schrama D; Hesbacher S; Angermeyer S; Schlosser A; Haferkamp S; Aue A; Adam C; Weber A; Schmidt M; Houben R Int J Cancer; 2016 Mar; 138(5):1153-62. PubMed ID: 26383606 [TBL] [Abstract][Full Text] [Related]
8. Characterization of functional domains in the Merkel cell polyoma virus Large T antigen. Houben R; Angermeyer S; Haferkamp S; Aue A; Goebeler M; Schrama D; Hesbacher S Int J Cancer; 2015 Mar; 136(5):E290-300. PubMed ID: 25208506 [TBL] [Abstract][Full Text] [Related]
9. Merkel Cell Carcinomas Arising in Autoimmune Disease Affected Patients Treated with Biologic Drugs, Including Anti-TNF. Rotondo JC; Bononi I; Puozzo A; Govoni M; Foschi V; Lanza G; Gafà R; Gaboriaud P; Touzé FA; Selvatici R; Martini F; Tognon M Clin Cancer Res; 2017 Jul; 23(14):3929-3934. PubMed ID: 28174236 [No Abstract] [Full Text] [Related]
11. RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells. Hesbacher S; Pfitzer L; Wiedorfer K; Angermeyer S; Borst A; Haferkamp S; Scholz CJ; Wobser M; Schrama D; Houben R Oncotarget; 2016 May; 7(22):32956-68. PubMed ID: 27121059 [TBL] [Abstract][Full Text] [Related]
12. Merkel Cell Polyomavirus Large T Antigen is Dispensable in G2 and M-Phase to Promote Proliferation of Merkel Cell Carcinoma Cells. Houben R; Ebert M; Hesbacher S; Kervarrec T; Schrama D Viruses; 2020 Oct; 12(10):. PubMed ID: 33066686 [TBL] [Abstract][Full Text] [Related]
13. Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma. Xu D; Jiang S; He Y; Jin X; Zhao G; Wang B NPJ Vaccines; 2021 Oct; 6(1):119. PubMed ID: 34611173 [TBL] [Abstract][Full Text] [Related]
14. The Ubiquitin-Specific Protease Usp7, a Novel Merkel Cell Polyomavirus Large T-Antigen Interaction Partner, Modulates Viral DNA Replication. Czech-Sioli M; Siebels S; Radau S; Zahedi RP; Schmidt C; Dobner T; Grundhoff A; Fischer N J Virol; 2020 Feb; 94(5):. PubMed ID: 31801860 [TBL] [Abstract][Full Text] [Related]
15. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration. Schrama D; Sarosi EM; Adam C; Ritter C; Kaemmerer U; Klopocki E; König EM; Utikal J; Becker JC; Houben R Int J Cancer; 2019 Aug; 145(4):1020-1032. PubMed ID: 30873613 [TBL] [Abstract][Full Text] [Related]
16. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus. Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806 [No Abstract] [Full Text] [Related]
17. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice. Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858 [TBL] [Abstract][Full Text] [Related]
18. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. Laude HC; Jonchère B; Maubec E; Carlotti A; Marinho E; Couturaud B; Peter M; Sastre-Garau X; Avril MF; Dupin N; Rozenberg F PLoS Pathog; 2010 Aug; 6(8):e1001076. PubMed ID: 20865165 [TBL] [Abstract][Full Text] [Related]